Inflammation in EVAR Clinical Trial
Official title:
Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in Endovascular Aneurysm Repair for Abdominal Aorticaneurysm
Verified date | April 2021 |
Source | University of Thessaly |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study investigated the association of chronic inflammatory markers with the clinical outcome after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm.
Status | Completed |
Enrollment | 230 |
Est. completion date | November 1, 2019 |
Est. primary completion date | February 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - AAA - Elective - EVAR Exclusion Criteria: - Emergency - Open surgery |
Country | Name | City | State |
---|---|---|---|
Greece | Univeristy of Thessaly | Larissa | Thessaly |
Lead Sponsor | Collaborator |
---|---|
University of Thessaly |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | NLR major cardiovascular events (MACE) | NLR indicator for major cardiovascular events (MACE) | Day 4 postopertively | |
Primary | PLR major cardiovascular events (MACE) | PLR indicator for major cardiovascular events (MACE) | Day 4 postopertively | |
Primary | NLR acute kidney injury (AKI) | NLR indicator for acute kidney injury (AKI) | Day 4 postopertively | |
Primary | PLR acute kidney injury (AKI) | PLR indicator for acute kidney injury (AKI) | Day 4 postopertively | |
Primary | NLR death | NLR indicator for death | Day 4 postopertively | |
Primary | PLR death | PLR indicator for death | Day 4 postopertively |